UNIVERSITY OF UTAH

Patent Owner

Compare Create Portfolio
9Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 18891
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 13222
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 11672
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9663
 
 
 
C07K PEPTIDES 9138
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 80131
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 8032
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 6334
 
 
 
G06F ELECTRIC DIGITAL DATA PROCESSING 56329
 
 
 
G01R MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES 28121

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2015/0075,987 DEVICES AND METHODS FOR SEPARATING NANOPARTICLESJul 08, 14Mar 19, 15[G01N]
2015/0072,352 SMALL MOLECULE-DEPENDENT SPLIT APTAMER LIGATIONMay 27, 14Mar 12, 15[G01N]
2015/0061,832 DIRECTLY OBSERVED THEARPY USING MOBILE TECHNOLOGYSep 05, 14Mar 05, 15[A61B, G07C, G06K]
2015/0063,532 MULTILEVEL COMPUTED TOMOGRAPHY FOR RADIALLY-SHIFTED FOCAL SPOTSAug 29, 13Mar 05, 15[G06T, G01N]
2015/0065,495 SUBSTITUTED- 1H-BENZO[D]IMIDAZOLE SERIES COMPOUNDS AS LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1) INHIBITORSAug 28, 14Mar 05, 15[C07D]
2015/0036,117 MASKLESS NANOIMPRINT LITHOGRAPHYJul 13, 12Feb 05, 15[G03F, B29C]
2015/0038,705 METHODS OF USE COMPRISING A BIOCIDAL POLYAMINEOct 06, 14Feb 05, 15[A01N, C07D, C07C]
2015/0030,050 ULTRASONIC TEMPERATURE MEASUREMENT DEVICEAug 05, 14Jan 29, 15[G01K]
2015/0033,370 MODEL AND METHOD FOR A TRANSGENIC BOVIDAE EXPRESSING CARDIAC FIBROSIS AND ASSOCIATED PATHOLOGYJul 25, 14Jan 29, 15[A01K, A61D]
2015/0024,998 ISOLATION, IDENTIFICATION, AND USES OF ANTIFUNGAL COMPOUNDSDec 20, 12Jan 22, 15[C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,980,196 Fluid-sparged helical channel reactor and associated methodsMar 15, 10Mar 17, 15[C10G, C07C, B01J]
8,975,027 Methods and compositions related to continuous flow thermal gradient PCRAug 08, 12Mar 10, 15[B01L, C12P, C12Q, G01N]
8,968,663 Monitoring membrane-bound proteinsJun 07, 11Mar 03, 15[G01N]
8,971,927 System and method for preventing cell phone use while drivingOct 06, 09Mar 03, 15[H04M, H04W]
8,965,485 Integrated surgical cutting systemNov 03, 08Feb 24, 15[G05B, A61B]
8,965,865 Method and system for adaptive discovery of content on a networkFeb 15, 08Feb 24, 15[G06F]
8,951,990 Use of alkylated semi-synthetic glycosaminoglycosan ethers for the treatment of dental disordersJan 07, 13Feb 10, 15[C08B, A61K, C08L]
8,952,319 Downhole deployable tools for measuring tracer concentrationsMar 04, 11Feb 10, 15[E21B, G01V]
8,953,239 Nanophotonic scattering structureSep 05, 13Feb 10, 15[G02B, G06F, B82Y]
8,945,156 Tissue fixationMay 19, 10Feb 03, 15[A61B, A61F]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0234,845 ORGANISM IDENTIFICATION PANELABANApr 01, 08Aug 21, 14[C12Q]
2014/0212,357 CONJUGATE OF A POLYMER, AN ANTI-ANGIOGENESIS AGENT AND A TARGETING MOIETY, AND USES THEREOF IN THE TREATMENT OF BONE RELATED ANGIOGENESIS CONDITIONSABANApr 02, 14Jul 31, 14[A61K]
2014/0161,906 USE OF ANGIOGENESIS ANTAGONISTS IN CONDITIONS OF ABNORMAL VENOUS PROLIFERATIONABANJun 12, 13Jun 12, 14[A61K]
2014/0089,003 PATIENT HEALTH RECORD SIMILARITY MEASUREABANSep 27, 12Mar 27, 14[G06Q]
2013/0312,966 IN SITU DECOMPOSITION OF CARBONYLS AT HIGH TEMPERATURE FOR FIXING INCOMPLETE AND FAILED WELL SEALSABANAug 01, 13Nov 28, 13[E21B]
2013/0281,410 METHODS FOR THE TREATMENT OF PSYCHIATRIC DISORDERSABANMay 13, 11Oct 24, 13[A61K]
2013/0202,578 COMPOSITIONS AND METHODS FOR SELECTIVELY PRODUCING SIRNAABANApr 22, 11Aug 08, 13[A61K]
2013/0184,609 3D FABRICATION OF NEEDLE TIP GEOMETRY AND KNIFE BLADEABANJul 20, 12Jul 18, 13[B29C]
2013/0177,523 GOLD PARTICLES AND METHODS OF MAKING AND USING THE SAME IN CANCER TREATMENTABANJul 13, 11Jul 11, 13[A61N, C08G, A61K]
2013/0172,985 CROSSLINKED HYDROGELS AND METHODS OF MAKING AND USING THEREOFABANJan 13, 11Jul 04, 13[A61N, A61F, C07K]
2013/0164,745 Methods for Assessing Risk for Cardiac Dysrythmia in a Human SubjectABANSep 17, 12Jun 27, 13[C12Q]
2013/0143,320 METHODS AND COMPOSITIONS FOR MANIPULATING THE GUIDED NAVIGATION OF ENDOTHELIAL TUBES DURING ANGIOGENESISABANOct 23, 12Jun 06, 13[C12N, C07K]
2013/0130,299 ELECTROCHEMICAL FLOW CYTOMETRYABANJan 11, 13May 23, 13[C12Q]
2013/0118,058 DIESEL MICROEMULSION BIOFUELSABANMay 10, 12May 16, 13[C10L]
2013/0122,301 PRESSURE SENSITIVE MICROPARTICLES FOR MEASURING CHARACTERISTICS OF FLUID FLOWABANDec 21, 12May 16, 13[C23C, G01F, G01N]
2013/0123,281 Compositions and Methods for Inhibition of TBL-1 Binding to Disease-Associated MoleculesABANNov 12, 12May 16, 13[C07D]
2013/0109,017 MULTIPLE MYELOMA PROGNOSIS AND TREATMENTABANDec 17, 12May 02, 13[C12Q, G01N]
2013/0102,534 COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIC ANGIOGENESIS AND VASCULAR PERMEABILITYABANOct 04, 12Apr 25, 13[A61K]
2013/0102,652 METHODS AND COMPOSITIONS RELATED TO MODIFIED ADENOSINES FOR CONTROLLING OFF-TARGET EFFECTS IN RNA INTERFERENCEABANMar 23, 11Apr 25, 13[C12N, C07H]
2013/0098,613 GEOTHERMAL WELL DIVERSION AGENT FORMED FROM IN SITU DECOMPOSITION OF CARBONYLS AT HIGH TEMPERATUREABANDec 13, 12Apr 25, 13[E21B]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.